Astrana Health Statistics
Share Statistics
Astrana Health has 49.12M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 49.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 4.40K |
| FTD / Avg. Volume | 1.47% |
Short Selling Information
The latest short interest is 1.90M, so 3.87% of the outstanding shares have been sold short.
| Short Interest | 1.90M |
| Short % of Shares Out | 3.87% |
| Short % of Float | 5.33% |
| Short Ratio (days to cover) | 7.5 |
Valuation Ratios
The PE ratio is 29.83 and the forward PE ratio is 28.05. Astrana Health 's PEG ratio is 0.66.
| PE Ratio | 29.83 |
| Forward PE | 28.05 |
| PS Ratio | 1.31 |
| Forward PS | 0.8 |
| PB Ratio | 2.95 |
| P/FCF Ratio | 45.63 |
| PEG Ratio | 0.66 |
Enterprise Valuation
Astrana Health Inc. has an Enterprise Value (EV) of 1.83B.
| EV / Earnings | 30.18 |
| EV / Sales | 1.32 |
| EV / EBITDA | 14.82 |
| EV / EBIT | 21.66 |
| EV / FCF | 46.16 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.45.
| Current Ratio | 2.11 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.45 |
| Total Debt / Capitalization | 31.19 |
| Cash Flow / Debt | 0.25 |
| Interest Coverage | 5.25 |
Financial Efficiency
Return on equity (ROE) is 0.1% and return on capital (ROIC) is 7.45%.
| Return on Equity (ROE) | 0.1% |
| Return on Assets (ROA) | 0.07% |
| Return on Capital (ROIC) | 7.45% |
| Revenue Per Employee | 770.37K |
| Profits Per Employee | 33.73K |
| Employee Count | 1.80K |
| Asset Turnover | 1.49 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 31.99M |
| Effective Tax Rate | 0.36 |
Stock Price Statistics
The stock price has increased by 3.82% in the last 52 weeks. The beta is 1.24, so Astrana Health 's price volatility has been higher than the market average.
| Beta | 1.24 |
| 52-Week Price Change | 3.82% |
| 50-Day Moving Average | 50.27 |
| 200-Day Moving Average | 45.75 |
| Relative Strength Index (RSI) | 25.74 |
| Average Volume (20 Days) | 299.19K |
Income Statement
In the last 12 months, Astrana Health had revenue of $1.39B and earned $60.72M in profits. Earnings per share was $1.3.
| Revenue | 1.39B |
| Gross Profit | 214.96M |
| Operating Income | 84.61M |
| Net Income | 60.72M |
| EBITDA | 123.69M |
| EBIT | 84.61M |
| Earnings Per Share (EPS) | 1.3 |
Balance Sheet
The company has $293.81M in cash and $321.01M in debt, giving a net cash position of -$27.21M.
| Cash & Cash Equivalents | 293.81M |
| Total Debt | 321.01M |
| Net Cash | -27.21M |
| Retained Earnings | 243.13M |
| Total Assets | 1.29B |
| Working Capital | 284.06M |
Cash Flow
In the last 12 months, operating cash flow was $68.23M and capital expenditures -$28.53M, giving a free cash flow of $39.70M.
| Operating Cash Flow | 68.23M |
| Capital Expenditures | -28.53M |
| Free Cash Flow | 39.70M |
| FCF Per Share | 0.85 |
Margins
Gross margin is 15.5%, with operating and profit margins of 6.1% and 4.38%.
| Gross Margin | 15.5% |
| Operating Margin | 6.1% |
| Pretax Margin | 6.48% |
| Profit Margin | 4.38% |
| EBITDA Margin | 8.92% |
| EBIT Margin | 6.1% |
| FCF Margin | 2.86% |
Dividends & Yields
ASTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3.46% |
| FCF Yield | 2.15% |
Analyst Forecast
The average price target for ASTH is $63, which is 67.9% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $63 |
| Price Target Difference | 67.9% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Apr 27, 2015. It was a backward split with a ratio of 1:10.
| Last Split Date | Apr 27, 2015 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 3.65 |
| Piotroski F-Score | 5 |